Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; R factor = 0.045; wR factor = 0.124; data-to-parameter ratio = 15.3.
In the title compound, C 19 H 16 O 4 , there are two 4-hydroxybenzyl substituents on the oxan-4-one (tetrahydropyran-4one) ring, which exhibits an envelope conformation. The dihedral angles between pyranone ring and the two benzene rings are 26.69 (9) and 36.01 (9) while the benzene rings make a dihedral angle of 20.88 (10) . In the crystal, molecules are linked by intermolecular O-HÁ Á ÁO hydrogen bonds into a supramolecular three-dimensional twofold interpenetrating hydrogen-bonded network.
Related literature
For the pharmacological activity or curcumin [systematic name (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione], see: Maheshwari et al. (2006) . For curcumin analogues, see: Liang et al. (2009) . For the synthesis of the title compound, see: Youssef et al. (2004) ; Du et al. (2006) . For related structures, see: Abaee et al. (2008) ; Du et al. (2006) . Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Symmetry codes: (i) Àx þ 3 2 ; Ày þ 2; z À 1 2 ; (ii) Àx þ 2; y þ 1 2 ; Àz þ 3 2 .
Data collection: SMART (Bruker, 2000) ; cell refinement: SAINT-Plus (Bruker, 2000) ; data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXTL.
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Comment
For thousands of years Eastern medicine has used curcumin, the major component of turmeric, for a wide range of health benefits, but only in recent times has its biological action been understood. Curcumin possesses a wide spectrum of pharmacological activities including anti-oxidant, anti-inflammatory, antiviral, antifungal, cancer chemo preventive, cancer chemotherapeutic properties (Maheshwari et al., 2006) . As the limitation of solubility, stability and activity of curcumin for clinical application, many series of curcumin analoges with a monoketone function have attracted interests in trial of improving the properties (Liang et al., 2009) . This class of compounds is readily synthesized by reacting a substituted benzaldehyde with tetrahydropyran-4-one; in the case of the title compound 4-hydroxybenzaldehyde was used as the reactant.
The compound was purified by re-crystallization from THF and characterized by NMR spectrum and ESI mass spectrum.
The analytical and spectroscopic data are consistent with the proposed structure given in Scheme 1. The molecular structure of the title compound contains the two 4-methylbenzyl substituents on the tetrahydropyran-4-one and the six-member ring adopts an envelope conformation with the flap oxygen atom displaced by 0.648 (8) Å from the plane of the other five atoms ( Figure 1 ).
Similar structures have been observed in the literature (Abaee et al., 2008; Du et al.,2006) .
The dihedral angles formed between the mean plane through the six atoms of the pyranone ring and two benzene rings of 4-methylbenzyl groups are 26.69 (9) and 36.01 (9)°, the corresponding dihedral angles between two benzene rings of 4-methylbenzyl groups is 20.88 (10) °.
In the crystal packing, intermolecular O-H···O hydrogen bonds (Figure 2, table 1) connect the molecules into a supramolecular three-dimensional two-fold interpenetrating hydrogen bonding network (Figure 3 ).
Experimental
The title compound was synthesized using a general procedure (Du et al.,2006; Youssef et al., 2004) 4-hydroxybenzaldehyde (0.01 mol) and tetrahydropyran-4-one (0.005 mol) were dissolved in THF and added 0.5 mL concentrated HCl as catalyst.
The mixture was warmed at 298-303 K for 12 h, cold water was added to precipitate the yellow compound. Crystals were obtained by recrystallization from THF. The formulation was established by the NMR spectrum and ESI mass spectrum. 1 H NMR (MSDO-d 6 , 300 MHz) δ (ppm): 10.03 (brs, 2H, -COH), 7.55 (s, 2H, -CCH=), 7.28 (d, J = 8.1, 4H, ArH), 6.85 (d, J = 8.1, ArH), 4.85 (s, 4H, -CCH 2 -O-CCH 2 -C). The ESI mass spectrum showed ions at 308.
Refinement
The C-bound H atoms were positioned geometrically and were included in the refinement in the riding-model approximation, with distances 0.96 (CH 3 ), 0.97 (CH 2 ) and 0.95 Å (aromatic); U iso (H) = 1.2Ueq(C) for H atoms on secondary and tertiary supplementary materials sup-2 C atoms, and U iso = 1.5Ueq(C) for methyl H atoms. The two water H atoms were located in a difference Fourier map and then refined as riding on the water O atom with U iso (H) = 1.5Ueq(O). Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2sigma(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) 
